Larimal

Larimal is a prescription artemisinin-based combination therapy (ACT) containing artemether and lumefantrine. It is used to treat acute, uncomplicated malaria infections caused by Plasmodium falciparum, including multi-drug resistant strains. The two active ingredients work synergistically to rapidly clear malaria parasites from the bloodstream.

Dosage by Body Weight

Larimal is administered as a 3-day treatment course consisting of 6 total doses. The first dose is taken immediately upon diagnosis, the second dose 8 hours later, and the remaining 4 doses are taken twice daily (morning and evening) for the next 2 days. It must be taken with fat-containing food or milk to ensure proper absorption.

  1. Body Weight
    Below 5 kg
    Dose
    Safety and efficacy not established
    Frequency
    Use only if prescribed
    Tracking Notes
    Not recommended for infants weighing less than 5 kg unless specifically advised by a doctor.
  2. Body Weight
    5-7 kg
    Dose
    1 tablet (Artemether 20 mg / Lumefantrine 120 mg) or equivalent suspension
    Frequency
    Twice daily for 3 days (6 doses total)
    Tracking Notes
    The first dose is given at 0 hours, second dose at 8 hours, and then twice daily at 12-hour intervals. Tablets can be crushed and mixed with water or milk for small children.
  3. Body Weight
    8-10 kg
    Dose
    1 tablet (Artemether 20 mg / Lumefantrine 120 mg) or equivalent suspension
    Frequency
    Twice daily for 3 days (6 doses total)
    Tracking Notes
    Must be administered with food, milk, or breast milk to enhance absorption.
  4. Body Weight
    11-15 kg
    Dose
    1 tablet (Artemether 20 mg / Lumefantrine 120 mg)
    Frequency
    Twice daily for 3 days (6 doses total)
    Tracking Notes
    Ensure the complete 6-dose course is finished even if the patient feels better before completion.
  5. Body Weight
    16-20 kg
    Dose
    2 tablets (Artemether 20 mg / Lumefantrine 120 mg per tablet)
    Frequency
    Twice daily for 3 days (6 doses total)
    Tracking Notes
    Dosage increases to 2 tablets per dose for children weighing 15 kg and above.

Formulation

TabletOral Suspension

Purpose

Treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum.

Generic Name

Artemether + Lumefantrine

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.